Literature DB >> 24431622

Reversible pure red cell aplasia of pregnancy: a therapeutic challenge.

Sunita Aggarwal1.   

Abstract

Entities:  

Keywords:  Pregnancy; Pure red cell aplasia

Year:  2012        PMID: 24431622      PMCID: PMC3664683          DOI: 10.1007/s13224-011-0069-9

Source DB:  PubMed          Journal:  J Obstet Gynaecol India        ISSN: 0975-6434


× No keyword cloud information.
  5 in total

Review 1.  The biology of pure red cell aplasia.

Authors:  E N Dessypris
Journal:  Semin Hematol       Date:  1991-10       Impact factor: 3.851

2.  Recurrent reversible pure red cell aplasia in pregnancy.

Authors:  R V Majer; P J Green
Journal:  Clin Lab Haematol       Date:  1988

3.  Reversible pure red-cell aplasia in pregnancy.

Authors:  I Miyoshi; T Hikita; P Koi; I Kimura
Journal:  N Engl J Med       Date:  1978-10-05       Impact factor: 91.245

4.  Hydrops foetalis in 3 infants of a mother with acquired chronic pure red cell aplasia: transitory red cell aplasia in 1 of the infants.

Authors:  B K Oie; J Hertel; M Seip; B Friis-Hansen
Journal:  Scand J Haematol       Date:  1984-11

Review 5.  Pure red cell aplasia of pregnancy: a distinct clinical entity.

Authors:  R I Baker; A Manoharan; E de Luca; C G Begley
Journal:  Br J Haematol       Date:  1993-11       Impact factor: 6.998

  5 in total
  3 in total

1.  Self-limiting pregnancy-associated pure red cell aplasia developing in two consecutive pregnancies: case report and literature review.

Authors:  Yoko Edahiro; Hajime Yasuda; Kiyoshi Ando; Norio Komatsu
Journal:  Int J Hematol       Date:  2019-12-09       Impact factor: 2.490

Review 2.  [Pregnancy induced erythroblastopenia: about a case and review of the literature].

Authors:  Drissi Jihad; Kouach Jaouad; Moussaoui Driss; Dehayni Mohamed
Journal:  Pan Afr Med J       Date:  2016-06-21

3.  Recurrent Pregnancy-Related Pure Red Cell Aplasia Responsive to Combined Corticosteroid and Azathioprine Therapy: A Management Dilemma

Authors:  Ashwin Rao; Rashmi Rao
Journal:  Turk J Haematol       Date:  2020-05-12       Impact factor: 1.831

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.